ReShape Lifesciences Inc (RSLS) - Product Pipeline Analysis, 2023 Update

Summary


ReShape Lifesciences Inc (ReShape) formerly Obalon Therapeutics Inc, designs, develops and commercializes minimally invasive medical devices to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShape Vest system is a implanted device allows weight reduction while keeping the stomach in place. It provides ReShapeCare virtual health coaching programme, which encourages healthy lifestyle modifications for all patients undergoing medically assisted weight reduction, and ReShape Diabetes Bloc-Stim Neuromodulation, a preclinical technology being developed for the treatment of type 2 diabetes mellitus. ReShape is headquartered in San Clemente, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ReShape Lifesciences Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


ReShape Lifesciences Inc Company Overview
ReShape Lifesciences Inc Company Snapshot
ReShape Lifesciences Inc Pipeline Products and Ongoing Clinical Trials Overview
ReShape Lifesciences Inc – Pipeline Analysis Overview
ReShape Lifesciences Inc - Key Facts
ReShape Lifesciences Inc - Major Products and Services
ReShape Lifesciences Inc Pipeline Products by Development Stage
ReShape Lifesciences Inc Ongoing Clinical Trials by Trial Status
ReShape Lifesciences Inc Pipeline Products Overview
Diabetes Bloc-Stim Neuromodulation Device
Diabetes Bloc-Stim Neuromodulation Device Product Overview
Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia
Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia Product Overview
Lap-Band 2.0 System
Lap-Band 2.0 System Product Overview
Maestro RF System
Maestro RF System Product Overview
Patient Compliance System
Patient Compliance System Product Overview
ReShape Vest
ReShape Vest Product Overview
ReShape Vest Clinical Trial
ReShape Lifesciences Inc - Key Competitors
ReShape Lifesciences Inc - Key Employees
ReShape Lifesciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ReShape Lifesciences Inc, Recent Developments
Aug 07, 2023: ReShape Lifesciences Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update
May 15, 2023: ReShape Lifesciences reports first quarter ended march 31, 2023 financial results and provides corporate update
Mar 22, 2023: ReShape Lifesciences to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update
Nov 14, 2022: ReShape Lifesciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Nov 07, 2022: ReShape Lifesciences to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update
Aug 15, 2022: ReShape Lifesciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 10, 2022: ReShape Lifesciences to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Update
May 23, 2022: ReShape Lifesciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 16, 2022: ReShape Lifesciences to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
Mar 31, 2022: ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: ReShape Lifesciences Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: ReShape Lifesciences Inc Pipeline Products by Equipment Type
Table 3: ReShape Lifesciences Inc Pipeline Products by Indication
Table 4: ReShape Lifesciences Inc, Key Facts
Table 5: ReShape Lifesciences Inc, Major Products and Services
Table 6: ReShape Lifesciences Inc Number of Pipeline Products by Development Stage
Table 7: ReShape Lifesciences Inc Pipeline Products Summary by Development Stage
Table 8: ReShape Lifesciences Inc Ongoing Clinical Trials by Trial Status
Table 9: ReShape Lifesciences Inc Ongoing Clinical Trials Summary
Table 10: Diabetes Bloc-Stim Neuromodulation Device - Product Status
Table 11: Diabetes Bloc-Stim Neuromodulation Device - Product Description
Table 12: Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Status
Table 13: Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Description
Table 14: Lap-Band 2.0 System - Product Status
Table 15: Lap-Band 2.0 System - Product Description
Table 16: Maestro RF System - Product Status
Table 17: Maestro RF System - Product Description
Table 18: Patient Compliance System - Product Status
Table 19: Patient Compliance System - Product Description
Table 20: ReShape Vest - Product Status
Table 21: ReShape Vest - Product Description
Table 22: ReShape Vest - An Investigative, Prospective, Non-randomized, Multi-center Study to Assess the Safety and Effectiveness of a Novel Gastric Restrictive Device, Call the ReShape Vest, in People Who Are Obese
Table 23: ReShape Lifesciences Inc, Key Employees
Table 24: ReShape Lifesciences Inc, Subsidiaries
Table 25: Glossary
List of Figures
Figure 1: ReShape Lifesciences Inc Pipeline Products by Equipment Type
Figure 2: ReShape Lifesciences Inc Pipeline Products by Development Stage
Figure 3: ReShape Lifesciences Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings